The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Preprint servers and what screening they do — the long version

This is a generated summary. It shows the 5 most-liked posts from a topic of 12, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
AP
au.pereiraTL2 Moderator15 Feb 2026#1

On the subject in the title: Preprint servers and what screening they do — the long version Working notes rather than a conclusion.

Session topic: PIONEER 6 (N Engl J Med, 2019). Please read it before posting; the discussion is much better when everyone has.

The question I would like us to start with is what the trial set out to estimate, rather than what it found. Once that is on the table we can talk about whether the design could have answered it, and only then about the numbers.

Specific things I would like covered: the population and how far it generalises, how discontinuation was handled, whether the comparator was a fair one, and what the absolute rather than relative effect looks like.

I will summarise at the end and the summary will feed the relevant digest page.

59 likes 5mo
SS
steady_stateTL3Regular6 Mar 2026#4

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

11 likes 5mo
CC
c.castellanosTL2 Moderator20 Mar 2026#7

post #6 answers the question as asked. The question underneath it is different.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

6 likes 4mo
YM
y.mensahTL3Wiki editor24 Mar 2026#8
steady_state, post #4: Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive. Go to post

On post #4 — agreed on the reasoning, with one qualification.

Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has different numbers, and the changes are not random — they tend to be in the direction of a smaller effect and a more careful claim.

16 likes in reply to #4 4mo
ND
n.duarteTL2 Moderator9 Apr 2026#12

Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to differ if the paper is later published differently.

18 likes 4mo

Read the full topic (12 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
A preprint whose numbers changed substantially at publication
A preprint whose numbers changed substantially at publication — setting out what I have, and where I think it stops being reliable. Session topic: SURMOUNT-2 ( Lancet , 2023). Please read it before posting;…
IBCNNDBRC+90 95 21k 9mo
Preprint servers and what screening they do
Preprint servers and what screening they do — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support of a claim I do not think it…
BTSRDNMRL+95 106 5.6k 4mo
[2026 update] Conference abstracts as evidence: the weakest common citation
Conference abstracts as evidence: the weakest common citation — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURMOUNT-4 ( JAMA , 2024) and finding…
JVVNJB 2 48k 7mo
The "under review" status pill and when a moderator applies it
Posting this under the heading it deserves: The "under review" status pill and when a moderator applies it Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024). Please read it…
NLAMDOVRV+96 119 17k 3mo
Tracking a preprint to publication: a worked example
Tracking a preprint to publication: a worked example Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 1 ( N Engl J Med , 2021). Please read it before…
VBUCRSDTSB+133 147 15k 7mo

Related topics — sharing the tags risk of bias, effect size, needs a source

TopicParticipantsRepliesViewsActivity
Sulfonylureas: the interaction most worth taking seriously
Sulfonylureas: the interaction most worth taking seriously Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
DOZCERFHKR+4 8 38k 6h
An 18-month record including the parts that went badly
An 18-month record including the parts that went badly — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated, because a number without a method is…
POBWBEPDED+77 81 17k 12h
Coming back to: A structured critique template this community uses
Posting this under the heading it deserves: A structured critique template this community uses Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with SURMOUNT-1 ( N Engl J Med , 2022)…
SOFAKHASMY+63 69 17k 18h
Follow-up: Levothyroxine timing: a real interaction with a simple fix
On the subject in the title: Levothyroxine timing: a real interaction with a simple fix Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is useful…
MSPMRSTNS+2 6 8.1k 4mo
Cagrilintide's dosing interval and the pharmacokinetics behind it
Cagrilintide's dosing interval and the pharmacokinetics behind it — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SELECT ( N Engl J Med ,…
BLCMABPRM+98 105 24k 10mo